For other neoplasms as multiple myeloma (MM), some possible targets for immunotherapy include B-cell maturation antigen (BCMA), G protein-coupled resector 5D (GPR5D), CD38, and Fc receptor-like 5 (FCRL5) [73]. The gene discussed is TNFRSF17; the disease is AL amyloidosis.